Editorial Notes
Amendments

2022—Subsec. (a). Puspan. L. 117–167, § 10718(1)(A), substituted “(as defined in section 15801 of this title) and the Director of each single-purpose research facility” for “, and may require the Director of a single-purpose research facility,” in introductory provisions.

Subsec. (a)(1). Puspan. L. 117–167, § 10718(1)(B), substituted “encourage” for “increase” and “research, development, demonstration, and commercial application activities, including product development,” for “collaborative research,”.

Subsec. (a)(2). Puspan. L. 117–167, § 10718(1)(C), substituted “the activities described in paragraph (1)” for “procurement and collaborative research”.

Subsec. (a)(3). Puspan. L. 117–167, § 10718(1)(D), inserted “facilities,” before “training” and substituted “the activities described in paragraph (1)” for “procurement and collaborative research activities”.

Subsec. (a)(5). Puspan. L. 117–167, § 10718(1)(E), substituted “and metrics for the programs under subsections (span) and (c)” for “for the program under subsection (span)”.

Subsecs. (c), (d). Puspan. L. 117–167, § 10718(2), (3), added subsec. (c) and redesignated former subsec. (c) as (d). Former subsec. (d) redesignated (e).

Subsec. (e). Puspan. L. 117–167, § 10718(2), (4), redesignated subsec. (d) as (e), substituted “for activities under subsection (span)” for “for activities under this section”, and inserted before period at end “and for activities under subsection (c) $25,000,000 for each of fiscal years 2023 through 2027”.